Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent, according to research…
Tag: Corona
Approval Of New Drug For Use In Bone Scans
The FDA has approved a New Drug Application (NDA) from the National Cancer Institute (NCI), part of the National Institutes of Health, for a new strength of a previously approved drug, Sodium…
Expression Analysis Announces Research Acceleration Grant Focusing On Kinase Mutations And Cancer
Expression Analysis (EA) announced a jointly sponsored research grant for up to eight American Cancer Society Grantees to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using…
Novel Approach In Radiation Therapy Spares Healthy Tissue, Could Improve Cancer Treatment
Medical physicists at Thomas Jefferson University and Jefferson’s Kimmel Cancer Center have demonstrated a new real-time tumor tracking technique that can help minimize the amount of radiation delivered to surrounding healthy tissue…
Cellular Oncology Expands Springer’s Cancer Research Portfolio
Springer and the International Society of Cellular Oncology (ISCO) will collaborate to publish Cellular Oncology starting this year. Cellular Oncology is the official journal of ISCO and publishes original papers and reviews…
Researchers Solve Decades-Old Medical Mysteries With The Help Of Genetics
The mystery began in 1976. Adolfo Pampena was diagnosed with a rare form of cancer that caused a strange combination of symptoms and was associated with the occurrence of multiple tumours in…
Where Immunotherapy’s Core Science Discovered, Ground-Breaking Cancer Treatment Begins
Cancer has been growing inside Peter Alfke’s prostate for 13 years. For several years, the best available treatment worked. “Then,” said Alfke, “it didn’t.” And the disease had moved into his bones….
H3 Biomedicine Launches To Discover And Develop Next Generation Cancer Treatments
H3 Biomedicine Inc. announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1)…
Early Successful Readout Of Tarceva Study In A Distinct Form Of Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc.,…
Cervical Cancer Jab Uptake Increases, UK
Over 84 per cent of girls aged 13-14 have helped protect themselves against cervical cancer by getting all three doses of the HPV vaccine and more than four million doses of the…
International Community Called Upon To Stop The Runaway Train Of Cancer In Africa
To coincide with World Cancer Day 2011, on 4 February, the Africa Oxford Cancer Foundation (AfrOx) and the European Society for Medical Oncology (ESMO) are working together to raise international awareness of…
Getting More Anti-Cancer Medicine Into The Blood
Scientists are reporting successful application of the technology used in home devices to clean jewelry, dentures, and other items to make anticancer drugs like tamoxifen and paclitaxel dissolve more easily in body…
Menopausal Hot Flashes Linked To A Significant Reduction In Breast Cancer Risk
Women who have experienced hot flushes and other symptoms of menopause may have a 50 percent lower risk of developing the most common forms of breast cancer than postmenopausal women who have…
Study Raises Safety Concerns About Experimental Cancer Approach
A study by researchers at Washington University School of Medicine in St. Louis has raised safety concerns about an investigational approach to treating cancer. The strategy takes aim at a key signaling…
CKU Developed Taiwan’s First Proactive Cancer Treatment System First-Generation Prototype
A Taiwanese research team, led by Prof. Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), has successfully developed a large-scale proactive cancer treatment system first-generation prototype which…